ACADIA PHARMACEUTICALS INC 4
4 · ACADIA PHARMACEUTICALS INC · Filed Mar 10, 2017
Insider Transaction Report
Form 4
Moore Terrence O
EVP, CHIEF COMMERCIAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2017-03-08+33,750→ 33,750 totalExercise: $36.54Exp: 2027-03-07→ Common Stock (33,750 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option vest and become exercisable on March 8, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.